Assert-IQ vs eMurmur ID
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if you require long-term, continuous cardiac monitoring for up to six years to detect infrequent or asymptomatic arrhythmias that may be missed by shorter-term methods. This tool is ideal for patients needing comprehensive, extended surveillance for suspected heart rhythm disorders, providing remote monitoring and proactive alerts for clinicians.
View Assert-IQ →Choose eMurmur ID if…
Choose eMurmur ID if you need an immediate, non-invasive, AI-powered solution for detecting and classifying heart murmurs during a patient encounter or via telehealth. This tool is best suited for healthcare providers seeking real-time decision support for suspected murmurs using an electronic stethoscope, facilitating rapid screening and initial assessment.
View eMurmur ID →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | eMurmur ID |
|---|---|---|
| Pricing | Enterprise | Unknown |
| Deployment | Hybrid | Cloud, Mobile, API integration |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID offers a more direct and interactive usability for healthcare providers at the point of care through its mobile app and web portal, providing real-time feedback and integrating with third-party stethoscopes. Assert-IQ, while offering remote monitoring and programming, is an implanted device with clinician interaction primarily through a cloud platform, making its usability less about direct, active engagement during an examination.
Clinical Value
TieBoth tools offer significant clinical value in distinct areas of cardiology. Assert-IQ excels in long-term, continuous arrhythmia monitoring with AI-driven false positive reduction, crucial for diagnosing intermittent conditions. eMurmur ID provides immediate, AI-powered decision support for heart murmur detection and classification at the point of care, addressing a critical need in primary care screening.
Pricing & Value
eMurmur IDWhile both tools have opaque pricing that requires direct vendor contact, eMurmur ID offers a 30-day free trial, allowing potential users to assess its value before committing. Assert-IQ does not offer a free trial, making it harder to evaluate its value proposition upfront.
Enterprise Readiness
eMurmur IDWhile Assert-IQ benefits from Abbott's established enterprise presence and hybrid deployment, eMurmur ID demonstrates stronger enterprise readiness through its explicit mention of API availability and extensive integration capabilities with major EHR systems and other healthcare IT platforms. Its flexible deployment options and support for various third-party stethoscopes also enhance its adaptability within diverse enterprise environments.
Innovation
TieBoth tools represent significant innovation in their respective domains. Assert-IQ innovates with its extended battery life, advanced AI for arrhythmia detection, and remote programming in an implantable device. eMurmur ID innovates by democratizing AI-assisted auscultation, providing real-time, expert-level murmur analysis at the point of care through a mobile and cloud solution compatible with existing stethoscope technology.
Support & Docs
Assert-IQAbbott Medical, as a large and established medical device company, provides comprehensive and easily accessible documentation for Assert-IQ, including detailed clinician and patient manuals, and dedicated technical support channels. While eMurmur ID offers email support, the breadth and depth of publicly available support resources and documentation appear more extensive for Assert-IQ.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | eMurmur ID |
|---|---|---|
| Name | Assert-IQ | eMurmur ID |
| Company | Abbott Medical | CSD Labs GmbH |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | AI-based analytics for heart murmur detection and classification, Mobile app for recording and displaying heart sounds, Web portal for data management and review, Operates with 3rd party electronic stethoscopes (e.g., Littmann 3200, Thinklabs One), Identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds, Real-time feedback/analysis results within seconds, Patient data management, Clinical decision support |
| Specialties | Cardiology, Internal Medicine | Cardiology, Family Medicine, Pediatrics |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and eMurmur ID.